- (A-1b).
- 25 (A-1b).
, , (B-3a).
.. - , (≥3334 . ), , .
:
- ( , ) 35% (A-1a).
:
- 17-α- (17-) , 1620- 250 34 .;
- 100-200 .
, (A-1b).
:
- , 105 / (A-1a).
( ).
: 500 4 per os 3 ;
- .
- (B-2a).
:
- (A-1a);
- - , (A-1a).
:
- ;
- 20 (, ). : 500 . 2 per os 7 300 2 peros 7 . I , , .
- .
: 1 per os 500 4 per os 7 .
:
- , , ;
- .
|
|
, :
1) ;
2)
3) I-II
4)
5)
:
: .. , 1 Ļ
: .. - , , .
: , 1 5 , .
:
1. Royal College of Obstetricians and Gynecologists TOCOLYTIC DRUGS FOR
WOMEN IN PRETERM LABOUR Clinical Guideline No. 1(B) October 2002
(Replaces Guideline No.1A Beta-agonists and No.1 Ritodrine)
2. National Guideline Clearinghouse: ACR Appropriateness Criteria for Growth
Disturbances:Risk of Intrauterine Growth Restriction- www.guideline.gov
3. , , 2008
4.
, , 2000, .
.. 2003
5. , ,
, 2007
6. , , , , 2010 .
7. , , -, 2012 .